最近有报道采用含免疫增强剂(精氨酸、RNA及ω3—脂肪酸)的肠内营养制剂(immune-enhancing formula，IEF)，认为可减少术后并发症。但还有不同看法，尚需有更多病例资料的证实。
基于4个网页-相关网页
结论：临床医师对营养支持的重视程度不断提高，肠内营养制剂的用药频度增长较快。
Conclusion: Nutritional support has attracted more and more clinical attention, and DDDs of the enteral nutrition increases rapidly.
结论肠内营养制剂(无糖专用型匀浆膳)的合理应用不仅可以控制血糖，增强营养，而且可以改善预后。
Conclusion a reasonable application of enteral nutrition (sugar-free meal special type homogenate) could not only control blood sugar, enhance nutrition, but also can improve the prognosis.
摘要：目的：为肠内营养(EN)制剂和肠外营养(PN)制剂的合理使用提供参考。
ABSTRACT: OBJECTIVE: To provide reference for the clinical use of enteral nutrition (en) and parenteral nutrition (PN) preparation.
应用推荐